AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. WRB
  4. [8-K] W.R. Berkley Corporation Reports Material Event

[8-K] W.R. Berkley Corporation Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

ANI Pharmaceuticals (ANIP) 鈥� Form 4 filing, 21 Jul 2025. Sr. VP, General Counsel & Secretary Meredith W. Cook reported a tax-related share withholding transaction on 18 Jul 2025.

  • Transaction type: Code F (shares withheld to satisfy taxes on vested restricted stock).
  • Securities affected: 2,071 common shares at an implied price of $66.30, total 鈮� $0.14 million.
  • Post-transaction holding: Cook now directly owns 76,874 common shares.
  • Derivative positions: No derivative transactions reported; prior option/RSU holdings unchanged.

The filing reflects routine tax withholding rather than an open-market sale. Cook retains >97% of her pre-vesting equity stake, signalling continued alignment with shareholders. No impact on the company鈥檚 operations, earnings outlook or governance structure was disclosed.

ANI Pharmaceuticals (ANIP) 鈥� Deposito Form 4, 21 lug 2025. Meredith W. Cook, Vicepresidente Senior, Consigliere Generale e Segretaria, ha comunicato una transazione di ritenuta azionaria per motivi fiscali il 18 lug 2025.

  • Tipo di transazione: Codice F (azioni trattenute per soddisfare le imposte sulle azioni vincolate maturate).
  • Azioni interessate: 2.071 azioni ordinarie a un prezzo implicito di 66,30 $, per un totale di circa 0,14 milioni di dollari.
  • Detenzione post-transazione: Cook detiene ora direttamente 76.874 azioni ordinarie.
  • Posizioni derivative: Nessuna transazione derivata segnalata; le precedenti opzioni/RSU rimangono invariate.

Il deposito riflette una ritenuta fiscale di routine e non una vendita sul mercato aperto. Cook mantiene oltre il 97% della sua partecipazione azionaria pre-vesting, segnalando un continuo allineamento con gli azionisti. Non sono stati comunicati impatti sulle operazioni aziendali, sulle previsioni degli utili o sulla struttura di governance.

ANI Pharmaceuticals (ANIP) 鈥� Presentaci贸n Formulario 4, 21 de julio de 2025. Meredith W. Cook, Vicepresidenta Senior, Asesora General y Secretaria, report贸 una transacci贸n de retenci贸n de acciones por motivos fiscales el 18 de julio de 2025.

  • Tipo de transacci贸n: C贸digo F (acciones retenidas para cubrir impuestos sobre acciones restringidas adquiridas).
  • Valores afectados: 2.071 acciones comunes a un precio impl铆cito de $66.30, total 鈮� $0.14 millones.
  • Tenencia despu茅s de la transacci贸n: Cook posee ahora directamente 76.874 acciones comunes.
  • Posiciones derivadas: No se reportaron transacciones derivadas; las opciones/RSU previas permanecen sin cambios.

La presentaci贸n refleja una retenci贸n fiscal rutinaria y no una venta en el mercado abierto. Cook conserva m谩s del 97% de su participaci贸n accionaria antes del vesting, lo que indica un alineamiento continuo con los accionistas. No se divulgaron impactos en las operaciones de la empresa, perspectivas de ganancias o estructura de gobierno.

ANI Pharmaceuticals (ANIP) 鈥� 2025雲� 7鞗� 21鞚� Form 4 鞝滌稖. 靾橃劃 攵�靷灔 瓴� 氩曤 瓿犽 氚� 牍勳劀鞚� Meredith W. Cook臧� 2025雲� 7鞗� 18鞚� 靹戈笀 甏�霠� 欤检嫕 鞗愳矞歆曥垬 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟.

  • 瓯半灅 鞙犿槙: 旖旊摐 F (旆摑 鞝滍暅 欤检嫕鞐� 雽�頃� 靹戈笀 雮╇秬毳� 鞙勴暅 欤检嫕 鞗愳矞歆曥垬).
  • 鞓來枼鞚� 氚涭潃 歃濌秾: 鞎旍嫓 臧�瓴� $66.30鞐� 2,071 氤错喌欤�, 齑� 鞎� $0.14氚彪.
  • 瓯半灅 頉� 氤挫湢 欤检嫕: Cook電� 順勳灛 歆侅爲 76,874 氤错喌欤茧ゼ 氤挫湢 欷戩瀰雼堧嫟.
  • 韺岇儩靸來拡 韽靺�: 韺岇儩靸來拡 瓯半灅 氤搓碃 鞐嗢潓; 鞚挫爠 鞓奠厴/RSU 氤挫湢電� 氤�霃� 鞐嗢潓.

鞚措矆 鞝滌稖鞚� 瓿店皽 鞁滌灔 毵る弰臧� 鞎勲媽 鞚检儊鞝侅澑 靹戈笀 鞗愳矞歆曥垬毳� 氚橃榿頃╇媹雼�. Cook電� 旆摑 鞝� 歆�攵勳潣 97% 鞚挫儊鞚� 鞙犾頃橂┌ 欤检＜鞕�鞚� 歆�靻嶌爜鞚� 鞚错暣甏�瓿勲ゼ 雮橅儉雰呺媹雼�. 須岇偓 鞖挫榿, 靾橃澋 鞝勲 霕愲姅 瓯半矂雱岇姢 甑“鞐� 氙胳箻電� 鞓來枼鞚� 瓿店皽霅橃 鞎婌晿鞀惦媹雼�.

ANI Pharmaceuticals (ANIP) 鈥� D茅p么t du Formulaire 4, 21 juillet 2025. Meredith W. Cook, Vice-Pr茅sidente Senior, Conseill猫re Juridique G茅n茅rale et Secr茅taire, a d茅clar茅 une op茅ration de retenue d鈥檃ctions li茅e 脿 l鈥檌mp么t le 18 juillet 2025.

  • Type de transaction : Code F (actions retenues pour satisfaire l鈥檌mp么t sur les actions restreintes acquises).
  • Titres concern茅s : 2 071 actions ordinaires 脿 un prix implicite de 66,30 $, soit environ 0,14 million de dollars.
  • Position apr猫s transaction : Cook d茅tient d茅sormais directement 76 874 actions ordinaires.
  • Positions d茅riv茅es : Aucune transaction d茅riv茅e signal茅e ; les options/RSU pr茅c茅dentes restent inchang茅es.

Le d茅p么t refl猫te une retenue fiscale de routine et non une vente sur le march茅 ouvert. Cook conserve plus de 97 % de sa participation avant acquisition, t茅moignant d鈥檜n alignement continu avec les actionnaires. Aucun impact sur les op茅rations, les perspectives de b茅n茅fices ou la gouvernance de l鈥檈ntreprise n鈥檃 茅t茅 divulgu茅.

ANI Pharmaceuticals (ANIP) 鈥� Form 4 Einreichung, 21. Juli 2025. Meredith W. Cook, Senior VP, General Counsel & Sekret盲rin, meldete am 18. Juli 2025 eine steuerbedingte Aktieneinbehaltstransaktion.

  • Transaktionstyp: Code F (Aktien einbehalten zur Begleichung von Steuern auf erworbene Restricted Stocks).
  • Betroffene Wertpapiere: 2.071 Stammaktien zu einem impliziten Preis von 66,30 $, insgesamt ca. 0,14 Mio. $.
  • Bestand nach der Transaktion: Cook besitzt nun direkt 76.874 Stammaktien.
  • Derivative Positionen: Keine derivativen Transaktionen gemeldet; vorherige Optionen/RSUs unver盲ndert.

Die Meldung spiegelt eine routinem盲脽ige Steuerabf眉hrung wider und keinen Verkauf am freien Markt. Cook beh盲lt 眉ber 97 % ihres Anteils vor dem Vesting, was auf eine weiterhin starke Ausrichtung auf die Aktion盲re hinweist. Keine Auswirkungen auf den Gesch盲ftsbetrieb, die Gewinnprognose oder die Governance-Struktur wurden bekannt gegeben.

Positive
  • Executive retains 76,874 shares, indicating continued equity exposure and alignment with shareholders.
Negative
  • 2,071 shares were disposed of (withheld for taxes), mildly increasing share float, though impact is immaterial.

Insights

TL;DR: Routine tax withholding; negligible market impact.

The Code F disposition simply covers payroll taxes on 4,820 vested RSUs. At 鈮� $137k, it is immaterial relative to ANIP鈥檚 average daily dollar volume and the executive鈥檚 remaining 76.9k-share stake. Because there was no discretionary sale, the signal value is neutral. Investors should not read this as a change in insider sentiment. Impact on float and EPS is de minimis.

ANI Pharmaceuticals (ANIP) 鈥� Deposito Form 4, 21 lug 2025. Meredith W. Cook, Vicepresidente Senior, Consigliere Generale e Segretaria, ha comunicato una transazione di ritenuta azionaria per motivi fiscali il 18 lug 2025.

  • Tipo di transazione: Codice F (azioni trattenute per soddisfare le imposte sulle azioni vincolate maturate).
  • Azioni interessate: 2.071 azioni ordinarie a un prezzo implicito di 66,30 $, per un totale di circa 0,14 milioni di dollari.
  • Detenzione post-transazione: Cook detiene ora direttamente 76.874 azioni ordinarie.
  • Posizioni derivative: Nessuna transazione derivata segnalata; le precedenti opzioni/RSU rimangono invariate.

Il deposito riflette una ritenuta fiscale di routine e non una vendita sul mercato aperto. Cook mantiene oltre il 97% della sua partecipazione azionaria pre-vesting, segnalando un continuo allineamento con gli azionisti. Non sono stati comunicati impatti sulle operazioni aziendali, sulle previsioni degli utili o sulla struttura di governance.

ANI Pharmaceuticals (ANIP) 鈥� Presentaci贸n Formulario 4, 21 de julio de 2025. Meredith W. Cook, Vicepresidenta Senior, Asesora General y Secretaria, report贸 una transacci贸n de retenci贸n de acciones por motivos fiscales el 18 de julio de 2025.

  • Tipo de transacci贸n: C贸digo F (acciones retenidas para cubrir impuestos sobre acciones restringidas adquiridas).
  • Valores afectados: 2.071 acciones comunes a un precio impl铆cito de $66.30, total 鈮� $0.14 millones.
  • Tenencia despu茅s de la transacci贸n: Cook posee ahora directamente 76.874 acciones comunes.
  • Posiciones derivadas: No se reportaron transacciones derivadas; las opciones/RSU previas permanecen sin cambios.

La presentaci贸n refleja una retenci贸n fiscal rutinaria y no una venta en el mercado abierto. Cook conserva m谩s del 97% de su participaci贸n accionaria antes del vesting, lo que indica un alineamiento continuo con los accionistas. No se divulgaron impactos en las operaciones de la empresa, perspectivas de ganancias o estructura de gobierno.

ANI Pharmaceuticals (ANIP) 鈥� 2025雲� 7鞗� 21鞚� Form 4 鞝滌稖. 靾橃劃 攵�靷灔 瓴� 氩曤 瓿犽 氚� 牍勳劀鞚� Meredith W. Cook臧� 2025雲� 7鞗� 18鞚� 靹戈笀 甏�霠� 欤检嫕 鞗愳矞歆曥垬 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟.

  • 瓯半灅 鞙犿槙: 旖旊摐 F (旆摑 鞝滍暅 欤检嫕鞐� 雽�頃� 靹戈笀 雮╇秬毳� 鞙勴暅 欤检嫕 鞗愳矞歆曥垬).
  • 鞓來枼鞚� 氚涭潃 歃濌秾: 鞎旍嫓 臧�瓴� $66.30鞐� 2,071 氤错喌欤�, 齑� 鞎� $0.14氚彪.
  • 瓯半灅 頉� 氤挫湢 欤检嫕: Cook電� 順勳灛 歆侅爲 76,874 氤错喌欤茧ゼ 氤挫湢 欷戩瀰雼堧嫟.
  • 韺岇儩靸來拡 韽靺�: 韺岇儩靸來拡 瓯半灅 氤搓碃 鞐嗢潓; 鞚挫爠 鞓奠厴/RSU 氤挫湢電� 氤�霃� 鞐嗢潓.

鞚措矆 鞝滌稖鞚� 瓿店皽 鞁滌灔 毵る弰臧� 鞎勲媽 鞚检儊鞝侅澑 靹戈笀 鞗愳矞歆曥垬毳� 氚橃榿頃╇媹雼�. Cook電� 旆摑 鞝� 歆�攵勳潣 97% 鞚挫儊鞚� 鞙犾頃橂┌ 欤检＜鞕�鞚� 歆�靻嶌爜鞚� 鞚错暣甏�瓿勲ゼ 雮橅儉雰呺媹雼�. 須岇偓 鞖挫榿, 靾橃澋 鞝勲 霕愲姅 瓯半矂雱岇姢 甑“鞐� 氙胳箻電� 鞓來枼鞚� 瓿店皽霅橃 鞎婌晿鞀惦媹雼�.

ANI Pharmaceuticals (ANIP) 鈥� D茅p么t du Formulaire 4, 21 juillet 2025. Meredith W. Cook, Vice-Pr茅sidente Senior, Conseill猫re Juridique G茅n茅rale et Secr茅taire, a d茅clar茅 une op茅ration de retenue d鈥檃ctions li茅e 脿 l鈥檌mp么t le 18 juillet 2025.

  • Type de transaction : Code F (actions retenues pour satisfaire l鈥檌mp么t sur les actions restreintes acquises).
  • Titres concern茅s : 2 071 actions ordinaires 脿 un prix implicite de 66,30 $, soit environ 0,14 million de dollars.
  • Position apr猫s transaction : Cook d茅tient d茅sormais directement 76 874 actions ordinaires.
  • Positions d茅riv茅es : Aucune transaction d茅riv茅e signal茅e ; les options/RSU pr茅c茅dentes restent inchang茅es.

Le d茅p么t refl猫te une retenue fiscale de routine et non une vente sur le march茅 ouvert. Cook conserve plus de 97 % de sa participation avant acquisition, t茅moignant d鈥檜n alignement continu avec les actionnaires. Aucun impact sur les op茅rations, les perspectives de b茅n茅fices ou la gouvernance de l鈥檈ntreprise n鈥檃 茅t茅 divulgu茅.

ANI Pharmaceuticals (ANIP) 鈥� Form 4 Einreichung, 21. Juli 2025. Meredith W. Cook, Senior VP, General Counsel & Sekret盲rin, meldete am 18. Juli 2025 eine steuerbedingte Aktieneinbehaltstransaktion.

  • Transaktionstyp: Code F (Aktien einbehalten zur Begleichung von Steuern auf erworbene Restricted Stocks).
  • Betroffene Wertpapiere: 2.071 Stammaktien zu einem impliziten Preis von 66,30 $, insgesamt ca. 0,14 Mio. $.
  • Bestand nach der Transaktion: Cook besitzt nun direkt 76.874 Stammaktien.
  • Derivative Positionen: Keine derivativen Transaktionen gemeldet; vorherige Optionen/RSUs unver盲ndert.

Die Meldung spiegelt eine routinem盲脽ige Steuerabf眉hrung wider und keinen Verkauf am freien Markt. Cook beh盲lt 眉ber 97 % ihres Anteils vor dem Vesting, was auf eine weiterhin starke Ausrichtung auf die Aktion盲re hinweist. Keine Auswirkungen auf den Gesch盲ftsbetrieb, die Gewinnprognose oder die Governance-Struktur wurden bekannt gegeben.

0000011544false00000115442025-07-212025-07-210000011544wrb:SubordinatedDebenturesDue20585.70Member2025-07-212025-07-210000011544wrb:SubordinatedDebenturesDue20595.10Member2025-07-212025-07-210000011544wrb:SubordinatedDebenturesDue2060425Member2025-07-212025-07-210000011544wrb:SubordinatedDebenturesDue20614125Member2025-07-212025-07-21
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 21, 2025
Commission File Number
1-15202


     W. R. BERKLEY CORPORATION     
(Exact name of registrant as specified in its charter)
Delaware22-1867895
(State or other jurisdiction of
incorporation or organization)		(I.R.S. Employer Identification No.)
  
475 Steamboat RoadGreenwichConnecticut06830
(Address of principal executive offices)(Zip Code)
(203)629-3000
(Registrant’s telephone number, including area code)
None
Former name, former address and former fiscal year, if changed since last report.

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of Each Class Trading Symbol Name of Each Exchange
on Which Registered
Common Stock, par value $.20 per share WRB New York Stock Exchange
5.700% Subordinated Debentures due 2058WRB-PENew York Stock Exchange
5.100% Subordinated Debentures due 2059WRB-PFNew York Stock Exchange
4.250% Subordinated Debentures due 2060WRB-PGNew York Stock Exchange
4.125% Subordinated Debentures due 2061WRB-PHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).    Emerging growth company     ☐    

W. R. Berkley Corporation         2

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐    

W. R. Berkley Corporation         3

Item 2.02 Results of Operations and Financial Condition.
Reference is made to the press release of W. R. Berkley Corporation (the “Company”) relating to the announcement of the Company’s results of operations for the second quarter of 2025. The press release was issued on July 21, 2025. A copy of the press release is attached to this Form 8-K as Exhibit 99.1 and is incorporated herein by reference.
The information contained herein shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

W. R. Berkley Corporation         4

Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit 99.1 Press Release dated July 21, 2025




W. R. Berkley Corporation         5



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

W. R. BERKLEY CORPORATION




By: /s/ Richard M. Baio
Name:Richard M. Baio
Title:Executive Vice President -
Chief Financial Officer




        


Date: July 21, 2025

W. R. Berkley Corporation         6

EXHIBIT INDEX


Exhibit:
99.1         Press Release dated July 21, 2025





Source:

FAQ

What did ANIP insider Meredith Cook report in the Form 4 filed 21-Jul-2025?

She disclosed 2,071 shares of ANIP common stock were withheld on 18-Jul-2025 to pay taxes on vested RSUs.

How many ANIP shares does Meredith Cook now own?

After the transaction, she directly holds 76,874 common shares.

Was this an open-market sale of ANIP stock?

No. The Code F designation indicates shares were withheld by the company for tax purposes, not sold on the market.

Does the Form 4 affect ANIP鈥檚 earnings or guidance?

No operational or financial guidance was provided; the filing only details insider share movements.

Is the 2,071-share disposition material to ANIP shareholders?

At 鈮� $137k and <0.01% of shares outstanding, the impact is not material to valuation or float.
Stock WRB logo
W.R Berkley

NYSE:WRB

WRB Rankings

#679 Ranked by Market Cap
#2103 Ranked by Dividends

WRB Latest News

Jul 21, 2025
W. R. Berkley Corporation Reports Second Quarter 2025 Results
Jul 18, 2025
W. R. Berkley Corporation Names Shadi Albert President of Vela Insurance Services
Jul 3, 2025
AM Best Affirms Credit Ratings of W. R. Berkley Corporation and Its Subsidiaries
Jun 24, 2025
W. R. Berkley Corporation to Announce Second Quarter 2025 Earnings on July 21, 2025
Jun 11, 2025
W. R. Berkley Corporation Declares Special Dividend and Increases Regular Quarterly Cash Dividend 12.5%

WRB Stock Data

26.35B
285.31M
24.33%
69.4%
2.28%
Insurance - Property & Casualty
Fire, Marine & Casualty Insurance
United States
GREENWICH